Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-033910
Filing Date
2010-06-11
Accepted
2010-06-11 19:04:48
Documents
1
Period of Report
2010-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4689
  Complete submission text file 0001209191-10-033910.txt   6624
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REGENERX BIOPHARMACEUTICALS, INC 3 BETHESDA METRO CENTER - SUITE 630 BETHESDA MD 20814
Business Address
Lyons C Neil (Reporting) CIK: 0001324648 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 10893531